On request of Diagonal Bio AB, company registration number 559248-8984, Nasdaq Stockholm AB has admitted the company's shares to trading on Nasdaq First North Growth Market Sweden with effect from July 16, 2021. As per today's date the company has a total of 9,148,663 shares. Shares Short name: DIABIO ------------------------------------------------------ Maximum number of shares: 9,148,663 ------------------------------------------------------ ISIN code: SE0015961826 ------------------------------------------------------ Round Lot: 1 ------------------------------------------------------ Order book ID: 227665 ------------------------------------------------------ Company Registration Number: 559248-8984 ------------------------------------------------------ Market segment: First North STO/8 ------------------------------------------------------ Tick Size table: MiFID II tick size table ------------------------------------------------------ Trading currency: SEK ------------------------------------------------------ Classification Code Name ----------------- 20 Health Care ----------------- 2010 Health Care ----------------- This information is distributed at the request of the Certified Adviser, Svensk Kapitalmarknadsgranskning AB. For further information, please call Svensk Kapitalmarknadsgranskning AB on +46 11 32 30 732.
© 2021 GlobeNewswire
